The Board of Directors of the California Institute for Regenerative Medicine (CIRM) has re-elected its founding President Robert Klein for a second term. Yesterday, Klein reiterated to the soundcard of the previous instruction (pdf) that only serve for a maximum of 6 months, until a suitable replacement can be found. "In 180 days, I will resign at that time, even if this process is not complete," Klein said just before the vote, which was unanimous except for one abstention.
Klein led the drive to pass the measure in 04 vote, which authorized $ 3 billion in sales of government bonds to fund research on stem cells in California. He had already said he would step down when his term expires Dec. 17. But earlier this month, the choice of his successor Klein, Canadian scientist Alan Bernstein, withdrew because of concerns that the law prohibits the state to a non-U.S citizen. To hold the job. (We do not know if this is true.) Klein then said he would stay on temporarily, if elected, but would not receive compensation for the position, which can pay up to $ 529,000.
The only abstention was CIRM board member and HIV / AIDS activist Jeff Sheehy, himself a candidate for the vice presidency. Before the vote, he expressed approval of the State Controller John Chiang opinion, who earlier this week wrote a letter calling the selection process for the president "fundamentally flawed" and urging the board to postpone the election and again. Sheehy also asked that no vote for him for the vice president. Nobody did.
Instead, the current vice presidents, Art Torres, a former state senator, and Duane Roth, CEO of the Alliance Pharmaceutical Corp., were re-elected.
0 Komentar